SPARK NS Translational Program — Therapeutics for Autism & Parkinson's (2027 cohort)
SPARK NS is accepting applications from academic researchers developing therapeutics for autism or Parkinson’s disease for its 2027 translational cohort. Selected projects receive milestone-based funding of up to $2,000,000 plus extensive hands-on support in drug development to reach translational objectives within about two years. Applications are evaluated on unmet clinical need, a robust/no…
SPARK NS is now accepting applications from academic researchers developing therapeutics for autism and Parkinson's disease for the 2027 Cohort of our translational research program. Selected projects will receive milestone-based funding of up to $2,000,0001 and extensive support in all aspects …
Funding Source
Awards & funding
Eligibility
SPARK NS accepts applications for the SPARK NS Translational Research Program from principal investigators with projects focused on developing therapeutics for autism, Parkinson's disease, and adjacent disorders at academic or nonprofit research institutions in the United States…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers